跳至主要内容
临床试验/NCT05472883
NCT05472883终止不适用

Identification of Human Circulating Adipocyte and Muscle Biomarkers Potentially Predictive of Diabetes Remission After Bariatric Surgery in Obese and Type 2 Diabetic Subjects.

University Hospital, Toulouse2 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2023年2月27日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
23
试验地点
2
主要终点
Correlation between plasma levels of 9 target molecules and diabetes remission

研究概览

简要总结

This study focuses on identifying potentially predictive human circulating adipocyte and muscle biomarkers of diabetes remission after bariatric surgery in obese type 2 diabetic (T2D) subjects.

详细描述

The study team at the Institute of Metabolic and Cardiovascular Diseases has recently identified several potential biomarkers (secreted by skeletal muscle and adipose tissue) of glucose homeostasis control using secretomic and metabolomic analyses. The goal of this study is to assess whether the addition of 9 adipocytes and myocytes plasma level could be associated with type 2 diabetes remission one year after bariatric surgery and would improve established clinical models of prediction of diabetes remission.

Thus, obese type 2 diabetes patients undergoing bariatric surgery will have 2 blood samples, a muscle sample and one adipose tissue sample withdrawn during the study. From those samples, concentrations of 9 candidate proteins is measured : GDF6, INHBB, IL17B, TGFB2, TIMP1, VTN, MDK, GDF15, and apoM

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Obese patients of at least grade 2 (body mass index ≥ 35 kg/m²)
  • Type 2 diabetics
  • About to undergo bariatric surgery at the Toulouse University Hospital
  • Affiliated or beneficiaries of a social security plan.
  • Having provided a free, informed and written consent, signed

排除标准

  • Type 1 diabetic subjects or Maturity-Onset Diabetes of the Youth.
  • Pregnant and breastfeeding women.
  • Vulnerable persons as defined in the Public Health Code: protected adults (guardianship, curators), unable to express their consent.

研究组 & 干预措施

study arm

Experimental

This arm consists of obese patients with type 2 diabetes who are scheduled for bariatric surgery.

干预措施: blood samples (Procedure)

study arm

Experimental

This arm consists of obese patients with type 2 diabetes who are scheduled for bariatric surgery.

干预措施: collection of body tissues (Procedure)

study arm

Experimental

This arm consists of obese patients with type 2 diabetes who are scheduled for bariatric surgery.

干预措施: routine care procedure (Procedure)

结局指标

主要结局

Correlation between plasma levels of 9 target molecules and diabetes remission

时间窗: At 12 months post-surgery

The correlation between plasma levels of 9 target molecules (1 for each molecule) and diabetes remission will be evaluated will be evaluated through plasmatic dosages. The plasma determination of apolipoprotein M will be performed by mass spectrometry, and the 8 other molecules will be determined by the ELISA technique. The dosage is measured in mmol/l. Complete remission of T2DM will be defined according to the following criteria: HbA1c \< 5.7% and fasting blood glucose \< 5.6 mmol/l. Partial remission of T2DM will be defined as: HbA1c between 5.7 and 6.5% and fasting blood glucose between 5.6 and 6.9 mmol/l without any antidiabetic treatment. Finally, the absence of remission will include patients whose HbA1c is greater than or equal to 6.5% or fasting blood glucose greater than or equal to 7 mmol/l with one or more antidiabetic treatments.

次要结局

  • Areas under the ROC curves of different logistic regression models fitted to known clinical prediction scores (DiaRem, Ad-DiaRem).(At 12 months post-surgery)
  • The expression level of genes encoding 9 biomarkers in the adipocyte and the muscle cell(At 12 months after surgery)
  • the kinetics of the plasma levels of each of the 9 molecules studied(At 12 months after the surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验